Scrip's Five Must-Know Things - 4 December 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CAR-Ts and malignancies; comeback for GSK’s Blenrep?; Novartis’s pipeline cull; FGF21 analogs in NASH; and a call to action from the Scrip Awards Lifetime Achievement winner. https://scrip.citeline.com/SC149443/Quick-Listen-Scrips-Five-MustKnow-Things